Final Amplatzer Data Still Support Narrow Use

ACC Conference Reporter

TCT 2016 | Washington, DC — Following FDA approval of the Amplatzer PFO Occluder device Friday, researchers released the final data from the RESPECT trial that had been requested by the agency as it weighed that decision. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics


< Back to Listings